These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31387620)

  • 1. Transplantation of MHC-mismatched mouse embryonic stem cell-derived thymic epithelial progenitors and MHC-matched bone marrow prevents autoimmune diabetes.
    Su M; Lin Y; He Z; Lai L
    Stem Cell Res Ther; 2019 Aug; 10(1):239. PubMed ID: 31387620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of mixed chimerism with MHC-mismatched but not matched bone marrow transplants results in thymic deletion of host-type autoreactive T-cells in NOD mice.
    Racine J; Wang M; Zhang C; Lin CL; Liu H; Todorov I; Atkinson M; Zeng D
    Diabetes; 2011 Feb; 60(2):555-64. PubMed ID: 21270266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
    Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
    J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.
    Hu R; Liu Y; Su M; Song Y; Rood D; Lai L
    Stem Cells Transl Med; 2017 Jan; 6(1):121-130. PubMed ID: 28170174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.
    Zhang M; Racine JJ; Lin Q; Liu Y; Tang S; Qin Q; Qi T; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2329-E2337. PubMed ID: 29463744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse embryonic stem cell-derived thymic epithelial cell progenitors enhance T-cell reconstitution after allogeneic bone marrow transplantation.
    Lai L; Cui C; Jin J; Hao Z; Zheng Q; Ying M; Boyd R; Zhao Y
    Blood; 2011 Sep; 118(12):3410-8. PubMed ID: 21791423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD mice.
    Racine JJ; Wang M; Zhang M; Zeng D
    Diabetes; 2014 Jun; 63(6):2051-62. PubMed ID: 24458357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas.
    Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y
    J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
    Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes resistance/susceptibility in T cells of nonobese diabetic mice conferred by MHC and MHC-linked genes.
    Ueno A; Cho S; Cheng L; Wang Z; Wang B; Yang Y
    J Immunol; 2005 Oct; 175(8):5240-7. PubMed ID: 16210629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of thymic epithelial cell progenitors by mouse embryonic stem cells.
    Lai L; Jin J
    Stem Cells; 2009 Dec; 27(12):3012-20. PubMed ID: 19824081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of embryonic stem cell-derived thymic epithelial progenitors expressing MOG induces antigen-specific tolerance and ameliorates experimental autoimmune encephalomyelitis.
    Su M; Song Y; He Z; Hu R; Rood D; Lai L
    J Autoimmun; 2015 Apr; 58():36-47. PubMed ID: 25618825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV; Leiter EH
    J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.